Medicare Price Cuts on 10 Drugs, Biggest 79% Drop This Year
Medicare's first round of drug-price negotiations slashes list prices on 10 widely used drugs by up to 79% starting J...
Benchmarks provide a reference point to gauge portfolio performance and risk. This intro explains how comparing returns against a relevant benchmark clarifies decisions and helps align goals.
22,975 articlesMedicare's first round of drug-price negotiations slashes list prices on 10 widely used drugs by up to 79% starting J...
A fresh look at ProShares UltraPro QQQ reveals that while the fund lists a 0.82% annual expense, the real erosion com...
Medicare Advantage mid-year network shifts can leave patients with fewer doctor options until January. Here's what af...
As workers reassess early retirement, a dividend-heavy portfolio could substitute lost full-time income. This piece b...
Vanguard has posted a high-level digital assets role, signaling a deeper push into crypto within its vast wealth busi...
As global markets evolve, two popular international ETFs—IXUS and SCHE—offer different paths to diversification. This...
Meta and Microsoft posted strong results, yet insider selling patterns diverged sharply. Meta's executives have been ...
Investors looking for steady upside in a volatile market often turn to utility leaders. Here are three durable cataly...
New federal data outline where gun thefts concentrate, revealing which states bear the heaviest burden and why safety...
Private and public sector leaders warn that Iran is expanding its AI-enabled cyber toolkit, raising the risk to banks...
Costco has delivered outsized gains over the past decade, while Walmart has paced a modern omnichannel comeback. The ...
Meta reports rising engineering output amid a larger headcount, fueling a split between efficiency and payroll. The m...